19/6/23 Presentation at NanoMed Europe 2023
Oral presentation at the 18th annual event of ETPN & the 5th NME conference merged into a unique event: NanoMed Europe 23 (NME23)
7/6/23 The EISA Awards 2023 Finalist
Shortlisted for the Best SEIS Investee Company category in the EISA Awards 2023 Article about the award day see: IF Magazine
1/6/23 Royal Society of Chemistry Emerging Technology Competition Finalist
Named finalist in the Royal Society of Chemistry Emerging Technology Competition in the health category
17/4/23 Presentation at ISTU Annual Symposium
Oral presentation at the International Society for Therapeutic Ultrasound (ISTU) annual symposium
23/2/23 Science Entrepreneur Club
Science Entrepreneur Club has spotlighted Apeikon Therapeutics, described our technology
23/1/23 Presentation at BioSeed 2023
Attended to BioSeed 2023 in London, a European equity investment event for early-stage life science companies.
6/12/22 Cancer Research Horizons Innovation and Entrepreneurship Nomination
Founder Maya Thanou was nominated by Cancer Research Horizon as one of the top 5 women entrepreneurs in the field of cancer technologies in the UK.
8/9/22 King’s 20 Accelerator Programme
Apeikon was selected to participate in King’s College London’s King’s 20 Accelerator Program, which is recognised as the flagship program of the Entrepreneurship Institute
4/7/22 Presentation at New Modalities in Pharmacology & Drug Discovery 2022
Poster presentation at the New Modalities in Pharmacology & Drug Discovery 2022, which is a joint conference hosted by BPS (British Pharmacological Society) and ELRIG UK
1/6/22 WAPG Launch Programme
Selected to participate in the WAPG Launch programme